INS and obesity disorder: Studies in animals have demonstrated that butyrate increases insulin sensitivity while reducing inflammation and food intake; a decrease in butyrate concentration due to both pregnancy and obesity can further influence the maternal and thus the infant’s gut metabolism and immune system (30, 37, 56).